Kindler does a shuffling act!
Jeffr
ey Kindler, Pfizer’s Chief Executive Officer has announced a turnaround in its leadership positions to re-arrange the drug company, struggling with augmented competition and the loss of exclusivity rights. Two key functions, Research and Finance, are the targetted two blocks. 57-year-old John LaMattina, the research and development chief of the company for a long time, and 45-year-old Alan Levin, the short-time chief financial officer will be retiring soon as a new replacement (rather successor) is found out. All these steps are a consequence of Kindler’s strategies to ‘transform’ Pfizer into a
For Complete IIPM Article, Click on IIPM Article
ey Kindler, Pfizer’s Chief Executive Officer has announced a turnaround in its leadership positions to re-arrange the drug company, struggling with augmented competition and the loss of exclusivity rights. Two key functions, Research and Finance, are the targetted two blocks. 57-year-old John LaMattina, the research and development chief of the company for a long time, and 45-year-old Alan Levin, the short-time chief financial officer will be retiring soon as a new replacement (rather successor) is found out. All these steps are a consequence of Kindler’s strategies to ‘transform’ Pfizer into aFor Complete IIPM Article, Click on IIPM Article
Source : IIPM Editorial, 2007
An IIPM and Professor Arindam Chaudhuri (Renowned Management Guru and Economist) Initiative
Labels: Arindam chaudhuri, IIPM, IIPM-News, IIPM-Publications, Management Guru, management school, renowned management guru
Rashmi Bansal Publisher Of JAMMAG Magazine Caught Red-Handed, for details click on the following links:-
posted by Pankaj Negi @ 10:21 PM
0 Comments:
Post a Comment
<< Home